Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Shares Outstanding (Diluted Average): 2021-2025

Historic Shares Outstanding (Diluted Average) for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $123.2 million.

  • ProQR Therapeutics N.V's Shares Outstanding (Diluted Average) rose 37.29% to $123.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.2 million, marking a year-over-year increase of 37.29%. This contributed to the annual value of $92.0 million for FY2024, which is 4.98% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Shares Outstanding (Diluted Average) of $123.2 million as of Q3 2025, which was up 3.28% from $119.2 million recorded in Q2 2025.
  • ProQR Therapeutics N.V's 5-year Shares Outstanding (Diluted Average) high stood at $123.2 million for Q3 2025, and its period low was $61.3 million during Q1 2021.
  • Over the past 3 years, ProQR Therapeutics N.V's median Shares Outstanding (Diluted Average) value was $88.6 million (recorded in 2024), while the average stood at $96.5 million.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Shares Outstanding (Diluted Average) decreased by 10.59% in 2022, and later spiked by 37.29% in 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Shares Outstanding (Diluted Average) (Quarterly) stood at $80.5 million in 2021, then dropped by 10.59% to $73.1 million in 2022, then grew by 19.25% to $87.2 million in 2023, then rose by 5.54% to $92.0 million in 2024, then surged by 37.29% to $123.2 million in 2025.
  • Its last three reported values are $123.2 million in Q3 2025, $119.2 million for Q2 2025, and $110.8 million during Q1 2025.